Investor Presentaiton slide image

Investor Presentaiton

Reimbursement pathway for Multi-Cancer Shield starts with colorectal cancer indication GUARDANT™ A shield Multi-Cancer ✓ shield CRC INVESTOR 20 DAY 23 108
View entire presentation